Sana Pharma proudly announces the release of a new medication in the Jordanian market.

Empaxa, Empagliflozin is an oral antidiabetic medication used for the treatment of type 2 diabetes patients. Empaxa has cardio and reno-protective effects, reduces body weight and blood pressure, and is well-tolerated without risk of hypoglycemia.